- Lobbying
- William AND Burke
Lobbying Arrangements Results for 'William Burke'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details H.R. 822, H.R. 1943, H.R. 6114, S-2969 |
GILEAD SCIENCES
|
RUBICON ADVISORS, LLC | |||
Details Pharmaceutical and Health Issues |
Fleming Pharmaceuticals
|
RUBICON ADVISORS, LLC | |||
Details Pharmaceutical prescription drug user fee |
RANBAXY PHARMACEUTICALS, INC.
|
RUBICON ADVISORS, LLC | |||
Details Pharmaceuticals |
Ranbaxy Pharmaceuticals
|
JMB Health Solutions, LLC | |||
Details budget/appropriations, economics/economic development |
The Boardroom
economic development policy and strategy consulting |
Lewis-Burke Associates, LLC | |||
Details Medicare |
Conscious Discipline
|
RUBICON ADVISORS, LLC | |||
Details FDA Citizen Petition Reform Affordable Healthcare Choices Act |
Osmotica Pharmaceuticals
|
RUBICON ADVISORS, LLC | |||
Details Orphan drugs |
HypoPARAthyroidism Association
|
RUBICON ADVISORS, LLC | |||
Details Healthcare: Medicare Reimbursement, Centers for Medicare & Medicaid Services |
AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS
|
RUBICON ADVISORS, LLC | |||
Details Pharmaceuticals, Bioshield |
HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH AND CO. KG
|
RUBICON ADVISORS, LLC | |||
Details Food and Drug Administration, Generic Drug User Fees |
Cipla USA, Inc.
|
RUBICON ADVISORS, LLC | |||
Details Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 |
WATSON PHARMACEUTICALS, INC
|
RUBICON ADVISORS, LLC | |||
Details GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES |
Avet Pharmaceuticals
|
RUBICON ADVISORS, LLC | |||
Details Client Awareness |
Mo Ibrahim Foundation
Philanthropic Organization |
The Washington Group | |||
Details Border Adjustment tax |
Albany Molecular Research Inc.
|
RUBICON ADVISORS, LLC | |||
Details Food and Drug Administration, COVID-19 Testing |
Pure Blue Diagnostics, a division of Pure Blue Medical
|
RUBICON ADVISORS, LLC | |||
Details Food and Drug Administration, Orphan Drugs |
Ascendis Pharma, Inc.
|
RUBICON ADVISORS, LLC | |||
Details Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
RUBICON ADVISORS, LLC | |||
Details Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues |
TEVA PHARMACEUTICALS USA
|
RUBICON ADVISORS, LLC | |||
Details Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus |
Lannett Company, Inc
|
RUBICON ADVISORS, LLC | |||
Details Physician Payment Rates, Electronic Health Records Incentives program |
College of American Pathologists
|
RUBICON ADVISORS, LLC | |||
Details Health Care |
Children's Hospital and Research Center
|
RUBICON ADVISORS, LLC | |||
Details Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA) |
Dynavax Technologies
|
RUBICON ADVISORS, LLC | |||
Details Generic Biologics S. 1695 Affordable Health Care Choices Act |
Insmed Incorporated
|
RUBICON ADVISORS, LLC | |||
Details Medicare |
State Mutual Insurance Company
|
RUBICON ADVISORS, LLC | |||
Details H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act |
Aquestive Therapeutics, Inc
|
RUBICON ADVISORS, LLC | |||
Details 340B Drug Discount Program |
Employee Eligibility Coalition
|
Powers Pyles Sutter & Verville, P.C. | |||
Details Economic development |
The Embassy of the People's Republic of Bangladesh
Diplomatic representative to the United States for the Republic of Panama |
The Washington Group, Inc. | |||
Details HR 2830 - Pension Protection Act of 2005 |
Coventry First
Sell existing life insurance policies. |
The Washington Group, Inc. | |||
Details Issues pertaining to high-dosage tutoring and ESSER funds. H.R. 8548, New Essential Education Discoveries Act of 2022, Issues pertaining to National Center for Advanced Development in Education (NC... |
Accelerate - The National Collaborative for Accelerated Learning
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details Monitoring legislative process |
Time Warner Cable
Cable TV Provider |
The Washington Group, Inc. | |||
Details HR 5576 and IRS Ruling 2006-27 |
Pacific Atlantic Group
Consulting Firm |
The Washington Group | |||
Details Pharmaceuticals HR 707, Restoration of America's Wire Act |
Office of Governor Nathan Deal
|
RUBICON ADVISORS, LLC | |||
Details Post BRAC redevelopment of Brunswick Naval Air Station Military Retention Activities |
The State of Maine
State Government |
The Washington Group, Inc. | |||
Details Federal procurement of tissue-graft products and establishing public/private research partnerships |
Celgene Cellular Therapeutics
Discovery and development of biotherapeutics |
The Washington Group, Inc. | |||
Details Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues |
Alliance to Prevent the Abuse of Medicines
|
RUBICON ADVISORS, LLC | |||
Details Flood Insurance |
The Financial Services Roundtable
Represents large integrated financial services companies |
The Washington Group, Inc. | |||
Details Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues |
Dr. Reddy's Laboratories, Ltd
|
RUBICON ADVISORS, LLC | |||
Details H.R. 5893, S.2321, FY 2024 Commerce, Justice, Science, and Related Agencies Appropriations, Issues pertaining to Regional Technology Hubs. Issues pertaining to EDA Reauthorization. |
America Achieves
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details Advocating for funding for Katrina related relief |
David R. Voelker
Investment Company |
The Washington Group, Inc. | |||
Details CFIUS Reform (HR 5337 & S 3549) Private investment - development in public infrastructure. |
Skanska Infrastructure Development
The company designs, builds, finances, operates and maintains highways and other infrastructure. |
The Washington Group, Inc. | |||
Details H.R. 5893, S. 2321, FY 2024 Commerce, Justice, Science, and Related Agencies Appropriations, Issues pertaining to NSF, NASA, and EDA funding for education, research, and workforce development. H.R.... |
State University System of Florida (SUS)
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details Passage of the Panama Free Trade Agreement |
The Embassy of the Republic of Panama
Diplomatic representative to the United States for the Republic of Panama |
The Washington Group, Inc. | |||
Details Work with federal government to integrate taggant system for use with Homeland Security issues and in Veteran's health facilities. |
Prime Technology, LLC
Develops technology to ensure that products are not counterfeit. |
The Washington Group, Inc. | |||
Details H.R. 6213, National Quantum Initiative Act Reauthorization, Issues pertaining to quantum research, infrastructure, and workforce development at NSF, DOE, NASA, and NIST. H.R. 4367, S. 2625, FY 2024... |
Northeastern University
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details H.R. 5893, S. 2321, FY 2024 Commerce, Justice, Science, and Related Agencies Appropriations, Issues pertaining to NSF STEM education, knowledge mobilization, partnerships, innovation, Centers for T... |
Education Reform Now Advocacy
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details FY 2025 Agriculture, Rural Development, FDA and Related Agencies Appropriations, Issues pertaining to rural programs, measurement and monitoring, ARS, and NIFA research and extension programs. FY ... |
North Dakota State University
|
LEWIS-BURKE ASSOCIATES, LLC | |||
Details Assist Congress in formulating preparedness for pandemic (avian flue) influenza outbreak; provide informatin on vaccine safety; and work to cover vaccines under the Vaccine Injury Compensation Prog... |
Sanofi Pasteur, Inc.
A US based manufacturer of vaccines and the only US manufacturer of injectable flu vaccine |
The Washington Group, Inc. | |||
Details On August 8, 2006 CMS published, “The Hospital Outpatient Prospective Payment System and CY 2007 Payment Rates." This proposed rule would reduce payments for Partial Hospitalization Programs (PHP)... |
Louisiana Association for Ambulatory Healthcare
Mental Health Provider |
The Washington Group | |||
Details P.L. 117-328, FY 2023 Consolidated Appropriations Act, Division B, Issues pertaining to NSF, regional tech hubs, and authorized STEM Education programs in the CHIPS and Science Act. P.L. 117-328, F... |
American Society for Engineering Education
|
LEWIS-BURKE ASSOCIATES, LLC |